Experiment 391168

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismSerenoa repens (ARECACEAE)
CitationREDECKER,KD: HOLSCHER,U:. (1998). EXTRACTUM SABAL FRUCTUS IN BENIGN PROSTASTIC HYPERPLASIA (BPH) CLINICAL TRIAL IN BPH STAGES I-II ACCORDING TO ALKEN.. 21(3)
Amount utilized
Compound isolated
Disease60 OUT-PATIENTS WITH BPH IN STAGES I-II ACCORDING TO ALKEN WERE TREATED WITH 160 MG SABAL EXTRACT TWICE PER DAY FOR A PERIOD OF TWELVE WEEKS IN AN OPEN PROGRESSIVE STUDY. IT WAS HERE POSSIBLE TO OBTAIN A STATISICALLY SIGNIFICANT AND PROGRESSIVELY RISING IMPROVEMENT OF UROFLOW VALUES, AS WELL AS A SIGNIFICANT IMPROVEMENT OF SUBJECTIVE REPORTS. TOLERANCE OF THE MEDICATION WAS VERY GOOD.
Dose amount320.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractETHER EXT
GenderMALE